UBS Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.75M | Buy |
569,956
+110,562
| +24% | +$479K | ﹤0.01% | 5092 |
|
|
2025
Q4 | $1.64M | Sell |
459,394
-32,583
| -7% | -$200K | ﹤0.01% | 5143 |
|
|
2025
Q3 | $4.38M | Buy |
491,977
+17,823
| +4% | +$181K | ﹤0.01% | 4170 |
|
|
2025
Q2 | $4.37M | Sell |
474,154
-133,866
| -22% | -$1.14M | ﹤0.01% | 4021 |
|
|
2025
Q1 | $5.22M | Buy |
608,020
+189,256
| +45% | +$1.79M | ﹤0.01% | 3739 |
|
|
2024
Q4 | $4.5M | Buy |
418,764
+288,707
| +222% | +$2.22M | ﹤0.01% | 3950 |
|
|
2024
Q3 | $739K | Sell |
130,057
-12,582
| -9% | -$72.6K | ﹤0.01% | 4913 |
|
|
2024
Q2 | $602K | Sell |
142,639
-272,844
| -66% | -$1.1M | ﹤0.01% | 4859 |
|
|
2024
Q1 | $2.11M | Buy |
415,483
+210,198
| +102% | +$1.18M | ﹤0.01% | 3893 |
|
|
2023
Q4 | $1.91M | Buy |
205,285
+103,904
| +102% | +$715K | ﹤0.01% | 3866 |
|
|
2023
Q3 | $664K | Sell |
101,381
-31,393
| -24% | -$250K | ﹤0.01% | 4430 |
|
|
2023
Q2 | $1.08M | Sell |
132,774
-49,576
| -27% | -$425K | ﹤0.01% | 4169 |
|
|
2023
Q1 | $1.56M | Sell |
182,350
-132,321
| -42% | -$1.32M | ﹤0.01% | 3684 |
|
|
2022
Q4 | $2.91M | Buy |
314,671
+266,716
| +556% | +$2.85M | ﹤0.01% | 3007 |
|
|
2022
Q3 | $494K | Sell |
47,955
-32,680
| -41% | -$345K | ﹤0.01% | 4353 |
|
|
2022
Q2 | $808K | Sell |
80,635
-271,881
| -77% | -$2.58M | ﹤0.01% | 3899 |
|
|
2022
Q1 | $4.34M | Buy |
352,516
+132,474
| +60% | +$1.63M | ﹤0.01% | 2665 |
|
|
2021
Q4 | $3.81M | Buy |
220,042
+41,029
| +23% | +$780K | ﹤0.01% | 3128 |
|
|
2021
Q3 | $3.21M | Buy |
179,013
+172,594
| +2,689% | +$3.44M | ﹤0.01% | 3145 |
|
|
2021
Q2 | $147K | Sell |
6,419
-60,185
| -90% | -$891K | ﹤0.01% | 5583 |
|
|
2021
Q1 | $995K | Buy |
66,604
+51,693
| +347% | +$565K | ﹤0.01% | 4250 |
|
|
2020
Q4 | $81K | Buy |
14,911
+12,411
| +496% | +$65.4K | ﹤0.01% | 5821 |
|
|
2020
Q3 | $11K | Sell |
2,500
-18,553
| -88% | -$79.9K | ﹤0.01% | 6747 |
|
|
2020
Q2 | $103K | Sell |
21,053
-11,884
| -36% | -$44.9K | ﹤0.01% | 5279 |
|
|
2020
Q1 | $104K | Sell |
32,937
-22,666
| -41% | -$79K | ﹤0.01% | 5256 |
|
|
2019
Q4 | $144K | Buy |
55,603
+20,239
| +57% | +$53.1K | ﹤0.01% | 5805 |
|
|
2019
Q3 | $112K | Buy |
35,364
+23,626
| +201% | +$68.2K | ﹤0.01% | 5703 |
|
|
2019
Q2 | $39K | Buy |
11,738
+9,238
| +370% | +$28.7K | ﹤0.01% | 6112 |
|
|
2019
Q1 | $8K | Sell |
2,500
-10,802
| -81% | -$25.8K | ﹤0.01% | 6927 |
|
|
2018
Q4 | $21K | Buy |
13,302
+2,366
| +22% | +$5.37K | ﹤0.01% | 6743 |
|
|
2018
Q3 | $30K | Buy |
10,936
+571
| +6% | +$1.61K | ﹤0.01% | 6536 |
|
|
2018
Q2 | $28K | Buy |
10,365
+4,052
| +64% | +$11.3K | ﹤0.01% | 6434 |
|
|
2018
Q1 | $17K | Sell |
6,313
-2,779
| -31% | -$7.85K | ﹤0.01% | 6498 |
|
|
2017
Q4 | $29K | Buy |
9,092
+1,613
| +22% | +$6.35K | ﹤0.01% | 6258 |
|
|
2017
Q3 | $31K | Sell |
7,479
-18
| -0.2% | -$80 | ﹤0.01% | 6131 |
|
|
2017
Q2 | $40K | Sell |
7,497
-2,473
| -25% | -$14.3K | ﹤0.01% | 5815 |
|
|
2017
Q1 | $57K | Sell |
9,970
-1,674
| -14% | -$8.65K | ﹤0.01% | 5427 |
|
|
2016
Q4 | $46K | Sell |
11,644
-3,711
| -24% | -$13.2K | ﹤0.01% | 5883 |
|
|
2016
Q3 | $56K | Buy |
15,355
+67
| +0.4% | +$282 | ﹤0.01% | 5417 |
|
|
2016
Q2 | $94K | Sell |
15,288
-53,408
| -78% | -$258K | ﹤0.01% | 5062 |
|
|
2016
Q1 | $337K | Buy |
68,696
+64,696
| +1,617% | +$285K | ﹤0.01% | 4089 |
|
|
2015
Q4 | $22K | Buy |
+4,000
| New | +$28.5K | ﹤0.01% | 6642 |
|
Other funds holding AVXL
VCM
SF
VPM